About
Oxcia is a biotechnology company focused on managing cell health and DNA repair through its O2-DDR technology platform. This platform targets oxidative stress, oxidative DNA damage, and DNA Damage Response to potentially cure diseases and extend lives. Their lead clinical candidates, OXC-101 for cancer and OXC-201 for pulmonary fibrosis, are developed for patients with these conditions.
Technology stack
detected 2026-06-22Est. monthly stack spend~$240/mo
Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
WordPress
Analytics
Google Analytics 4
SEO
Yoast SEO
Video
Vimeo
Cookie consent
Cookiebot
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Oxcia do?
Oxcia is a biotechnology company focused on managing cell health and DNA repair through its O2-DDR technology platform. This platform targets oxidative stress, oxidative DNA damage, and DNA Damage Response to potentially cure diseases and extend lives. Their lead clinical candidates, OXC-101 for cancer and OXC-201 for pulmonary fibrosis, are developed for patients with these conditions.
Where is Oxcia headquartered?
Oxcia is headquartered in San Francisco, United States.
When was Oxcia founded?
Oxcia was founded in 2022.
What industry does Oxcia operate in?
Oxcia operates in Agentic AI, AI Agent, Workflow Automation, Business Process Automation, Enterprise Software, API Platform.
How many employees does Oxcia have?
Oxcia has approximately 12 people on record.